Isla, Dolores
Lopez-Brea, Marta
Espinosa, María
Arrabal, Natalia
Pérez-Parente, Diego
Carcedo, David
Bernabé-Caro, Reyes
Article History
Received: 4 August 2022
Accepted: 8 January 2023
First Online: 16 January 2023
Declarations
:
: Not applicable.
: Not applicable.
: ML-B received speaker or consulting fees from Roche, Merck, BMS, AstraZeneca, Lilly, Pfizer and Takeda. DI received consulting fees or honorarium from MSD, Roche, Astrazeneca, Amgen, Pfizer, Sanofi, Bayer, BMS, GSK, Janssen, Takeda and BI, and received payments for lectures including service on speakers bureaus from Amgen Atrazeneca, Bayer, BMS, Roche, MSD, Pfizer and Takeda. RB-C received grants from Roche, consulting fees or honorarium from Roche, MSD, Astra, Bristol, support for travel to meetings for the study, manuscript preparation or other purposes Roche, MSD, Astra, Bristol, Pfizer and fees for participation in review activities such as data monitoring boards from Janssen. ME has not any conflicts of interest to declare. NA and DP are employees of Roche. DC is employee of Hygeia Consulting which received funding from Roche to conduct the analysis.